Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19

Ann Intern Med. 2020 Aug 18;173(4):324. doi: 10.7326/L20-0895.

Authors

Huilan Zhang¹, Cong-Yi Wang¹, Peng Zhou², Huihui Yue¹, Ronghui Du³

Affiliations

¹ Center for Biomedical Research, NHC Key Laboratory of Respiratory Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China (H.Z., C.W., H.Y.).
² CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China (P.Z.).
³ Wuhan Pulmonary Hospital, Wuhan, China (R.D.).

PMID: 32805177
DOI: 10.7326/L20-0895

No abstract available

Publication types

Letter
Comment

MeSH terms

Betacoronavirus*
COVID-19
Coronavirus Infections / epidemiology*
Humans
Pandemics*
Pneumonia, Viral / epidemiology*
SARS-CoV-2